Endoscopic Retrograde Cholangiopancreatography In Patients Older Than 65Years Old With Obstructive Jaundice: Efficacy And Outcome
Primary Purpose
Obstructive Jaundice
Status
Not yet recruiting
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Endoscopic retrograde cholangiopancreatography
Sponsored by
About this trial
This is an interventional screening trial for Obstructive Jaundice
Eligibility Criteria
Inclusion Criteria: patients with obstructive jaundice older than 18 years old Exclusion Criteria: 1. patients who refuse consent 2. patients under 18 years old
Sites / Locations
- Sohag university Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
group A
group B
Arm Description
patients with obstructive jaundice equal or older than 65 years old
patients with obstructive jaundice younger than 65 years old
Outcomes
Primary Outcome Measures
Pancreatitis
diagnosed by post ERCP elevation of serum amylase and lipase
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT06093048
Brief Title
Endoscopic Retrograde Cholangiopancreatography In Patients Older Than 65Years Old With Obstructive Jaundice: Efficacy And Outcome
Official Title
Endoscopic Retrograde Cholangiopancreatography In Patients Older Than 65Years Old With Obstructive Jaundice: Efficacy And Outcome
Study Type
Interventional
2. Study Status
Record Verification Date
October 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
November 2023 (Anticipated)
Primary Completion Date
October 2024 (Anticipated)
Study Completion Date
October 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Sohag University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The incidence of pancreato-biliary disorders ,including malignancy, is increasing in elderly patients. Endoscopic retrograde cholangiopancreatography (ERCP) is a well-known therapeutic tool for these pancreato-biliary disorders.
In general, old age is defined as being more than 65 years of age by the World Health Organization. The increase in the domestic aged population is related to the increasing demand for therapeutic ERCP in elderly patients with pancreato-biliary disorders. Common bile duct stones and cancer account for70 % of all jaundice cases in patients over the age of 65 years . This is related to increasing prevalences of cholelithiasis, choledocholithiasis, and malignancy with advancing age .
Endoscopic Retrograde Cholangiopancreatography(ERCP) represents the gold standard technique for the treatment of biliary or pancreatic tract pathology, and it could be often performed with therapeutic intent by realizing procedures such as insertion of bile duct stents and/or endoscopic sphincterotomy. However, evidence about its safety in the elderly is still controversial.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obstructive Jaundice
7. Study Design
Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
group A
Arm Type
Active Comparator
Arm Description
patients with obstructive jaundice equal or older than 65 years old
Arm Title
group B
Arm Type
Active Comparator
Arm Description
patients with obstructive jaundice younger than 65 years old
Intervention Type
Procedure
Intervention Name(s)
Endoscopic retrograde cholangiopancreatography
Intervention Description
saftey and outcome in patients older than 65 years old
Primary Outcome Measure Information:
Title
Pancreatitis
Description
diagnosed by post ERCP elevation of serum amylase and lipase
Time Frame
12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
patients with obstructive jaundice older than 18 years old
Exclusion Criteria:
1. patients who refuse consent 2. patients under 18 years old
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
mohamed E mahmoud, spcialist
Phone
01280711516
Email
mohamed.hassan4@med.sohag.edu.eg
First Name & Middle Initial & Last Name or Official Title & Degree
Hassan A Hassanein, professor
Phone
01003459741
Facility Information:
Facility Name
Sohag university Hospital
City
Sohag
Country
Egypt
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Magdy M Amin, professor
12. IPD Sharing Statement
Citations:
PubMed Identifier
28428722
Citation
Zhang ZM, Liu Z, Liu LM, Zhang C, Yu HW, Wan BJ, Deng H, Zhu MW, Liu ZX, Wei WP, Song MM, Zhao Y. Therapeutic experience of 289 elderly patients with biliary diseases. World J Gastroenterol. 2017 Apr 7;23(13):2424-2434. doi: 10.3748/wjg.v23.i13.2424.
Results Reference
background
PubMed Identifier
27565508
Citation
Ukkonen M, Siiki A, Antila A, Tyrvainen T, Sand J, Laukkarinen J. Safety and Efficacy of Acute Endoscopic Retrograde Cholangiopancreatography in the Elderly. Dig Dis Sci. 2016 Nov;61(11):3302-3308. doi: 10.1007/s10620-016-4283-2. Epub 2016 Aug 26.
Results Reference
background
PubMed Identifier
35433228
Citation
Perisetti A, Goyal H, Sharma N. Clinical safety and outcomes of glucagon use during endoscopic retrograde cholangiopancreatography (ERCP). Endosc Int Open. 2022 Apr 14;10(4):E558-E561. doi: 10.1055/a-1747-3242. eCollection 2022 Apr.
Results Reference
background
PubMed Identifier
25040209
Citation
Holt BA. Increased severity of post-endoscopic retrograde cholangiopancreatography complications in the elderly: an issue to be addressed. Dig Endosc. 2014 Jul;26(4):534-5. doi: 10.1111/den.12298. No abstract available.
Results Reference
background
Learn more about this trial
Endoscopic Retrograde Cholangiopancreatography In Patients Older Than 65Years Old With Obstructive Jaundice: Efficacy And Outcome
We'll reach out to this number within 24 hrs